Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ... Journal of clinical oncology: official journal of the American Society of …, 2007 | 1066 | 2007 |
ABT-888, an orally active poly (ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models CK Donawho, Y Luo, Y Luo, TD Penning, JL Bauch, JJ Bouska, ... Clinical cancer research 13 (9), 2728-2737, 2007 | 900 | 2007 |
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 825 | 2020 |
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy AB Sharabi, M Lim, TL DeWeese, CG Drake The lancet oncology 16 (13), e498-e509, 2015 | 794 | 2015 |
Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ... Jama 299 (23), 2760-2769, 2008 | 779 | 2008 |
Stereotactic radiation therapy augments antigen-specific PD-1–mediated antitumor immune responses via cross-presentation of tumor antigen AB Sharabi, CJ Nirschl, CM Kochel, TR Nirschl, BJ Francica, E Velarde, ... Cancer immunology research 3 (4), 345-355, 2015 | 614 | 2015 |
The life and death of DNA-PK SJ Collis, TL DeWeese, PA Jeggo, AR Parker Oncogene 24 (6), 949-961, 2005 | 614 | 2005 |
The role of inflammation in the pathogenesis of prostate cancer WG Nelson, AM De Marzo, TL DeWEESE, WB Isaacs The Journal of urology 172 (5), S6-S12, 2004 | 530 | 2004 |
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy TL DeWeese, H van der Poel, S Li, B Mikhak, R Drew, M Goemann, ... Cancer research 61 (20), 7464-7472, 2001 | 529 | 2001 |
Long‐term effects of androgen deprivation therapy in prostate cancer patients S Basaria, J Lieb, AM Tang, T DeWeese, M Carducci, M Eisenberger, ... Clinical endocrinology 56 (6), 779-786, 2002 | 434 | 2002 |
High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities J Wong, E Armour, P Kazanzides, I Iordachita, E Tryggestad, H Deng, ... International Journal of Radiation Oncology* Biology* Physics 71 (5), 1591-1599, 2008 | 371 | 2008 |
Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image … N Mariados, J Sylvester, D Shah, L Karsh, R Hudes, D Beyer, S Kurtzman, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 971-977, 2015 | 358 | 2015 |
Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial DA Hamstra, N Mariados, J Sylvester, D Shah, L Karsh, R Hudes, D Beyer, ... International Journal of Radiation Oncology* Biology* Physics 97 (5), 976-985, 2017 | 342 | 2017 |
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity S Yegnasubramanian, MC Haffner, Y Zhang, B Gurel, TC Cornish, Z Wu, ... Cancer research 68 (21), 8954-8967, 2008 | 341 | 2008 |
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells X Lin, M Tascilar, WH Lee, WJ Vles, BH Lee, R Veeraswamy, K Asgari, ... The American journal of pathology 159 (5), 1815-1826, 2001 | 307 | 2001 |
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 … AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ... Jama 319 (9), 896-905, 2018 | 301 | 2018 |
Evaluation of safety in a radiation oncology setting using failure mode and effects analysis EC Ford, R Gaudette, L Myers, B Vanderver, L Engineer, R Zellars, ... International Journal of Radiation Oncology* Biology* Physics 74 (3), 852-858, 2009 | 286 | 2009 |
Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment AM De Marzo, TL DeWeese, EA Platz, AK Meeker, M Nakayama, ... Journal of cellular biochemistry 91 (3), 459-477, 2004 | 281 | 2004 |
System for robotically assisted prostate biopsy and therapy with intraoperative CT guidance G Fichtinger, TL DeWeese, A Patriciu, A Tanacs, D Mazilu, JH Anderson, ... Academic radiology 9 (1), 60-74, 2002 | 252 | 2002 |
Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors SJ Collis, MJ Swartz, WG Nelson, TL DeWeese Cancer research 63 (7), 1550-1554, 2003 | 249 | 2003 |